Koponen Petri, Vuononvirta Juho, Nuolivirta Kirsi, Helminen Merja, He Qiushui, Korppi Matti
From the *Paediatric Research Centre, Tampere University and University Hospital, Tampere; †Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare, Turku; and ‡Seinäjoki Central Hospital, Seinajoki, Finland.
Pediatr Infect Dis J. 2014 May;33(5):463-6. doi: 10.1097/INF.0000000000000253.
Toll-like receptors (TLRs) are a pivotal part of the innate immunity system. Variations in TLR genes have been connected to autoimmune conditions, such as allergy and asthma. The TLR2 subfamily comprises TLR1, TLR2, TLR6 and TLR 10. We hypothesized that polymorphism of the TLR2 subfamily may be associated with prevalence of post-bronchiolitic asthma and/or atopy.
TLR1rs5743618, TLR2rs5743708 and TLR6rs5743810 single nucleotide polymorphisms of 133 children who had been hospitalized for bronchiolitis at <6 months of age were analyzed. Doctor-diagnosed asthma and atopy as well as their occurrence during the first 6 years of life were evaluated during a follow-up visit.
At the mean age of 6.4 years, asthma was present in 17 (13%) patients, there was asthma diagnosis during the first 6 years of life in 39 (29%) and current doctor-diagnosed allergic rhinitis in 57 (43%) patients. Twenty-four (24%) children with G/G genotype in TLR1 rs5743618 were diagnosed to have asthma between 1 and 6 years of age (vs. 13 (38%) of those with G/T or T/T genotypes; P = 0.04). In addition, 11/60 (18%) children with TLR6 rs5743810 C/T versus 36/73 (49%) children of other genotypes had atopic eczema at follow up. Only 2 children (8%) with wild genotype in all investigated single nucleotide polymorphisms had asthma during the first 6 years of life (vs. 30% in those with variant genotype of TLR1, TLR2 and/or TLR6).
In this study, we demonstrated that TLR1 rs5743618 was associated with asthma and atopic eczema during the first 6 years of life after early bronchiolitis. In addition, TLR6 rs5743810 was associated with present atopy at preschool age.
Toll样受体(TLRs)是先天性免疫系统的关键组成部分。TLR基因的变异与自身免疫性疾病相关,如过敏和哮喘。TLR2亚家族包括TLR1、TLR2、TLR6和TLR10。我们推测TLR2亚家族的多态性可能与细支气管炎后哮喘和/或特应性疾病的患病率有关。
分析了133例6个月龄前因细支气管炎住院的儿童的TLR1rs5743618、TLR2rs5743708和TLR6rs5743810单核苷酸多态性。在随访期间评估医生诊断的哮喘和特应性疾病以及它们在生命最初6年中的发生情况。
在平均年龄6.4岁时,17例(13%)患者患有哮喘,39例(29%)在生命的前6年被诊断为哮喘,57例(43%)患者目前被医生诊断为过敏性鼻炎。TLR1 rs5743618基因G/G基因型的24例(24%)儿童在1至6岁之间被诊断为哮喘(而G/T或T/T基因型的儿童为13例(38%);P = 0.04)。此外,TLR6 rs5743810 C/T基因型的11/60例(18%)儿童与其他基因型的36/73例(49%)儿童在随访时有特应性湿疹。在所有研究的单核苷酸多态性中,只有2例(8%)野生基因型儿童在生命的前6年患有哮喘(而TLR1、TLR2和/或TLR6变异基因型的儿童为30%)。
在本研究中,我们证明TLR1 rs5743618与早期细支气管炎后生命最初6年中的哮喘和特应性湿疹有关。此外,TLR6 rs5743810与学龄前目前的特应性疾病有关。